Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20163 in Healthy Volunteers

Status

UNKNOWN

Phases

Phase 1

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03005223

Enrollment

Registered

2016-12-29

Start date

2017-01-04

Completion date

2017-06-30

Last updated

2017-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

A randomized, open label, crossover study to explore drug-drug interactions between DWC20155 / DWC20156 and DWC20163 in Healthy Volunteers

Interventions

DRUGCo-administration of DWC20155/DWC20156

DRUGDWC20163

Study design

Allocation

RANDOMIZED

Intervention model

CROSSOVER

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

MALE

Age

19 Years to 45 Years

Healthy volunteers

Yes

Inclusion criteria

* Accepts healthy volunteers

Exclusion criteria

* Who has allergy to investigational product

Design outcomes

Primary

Measure	Time frame
Maximum Plasma Concentration (Cmax)	0 ~ 24 hours
Area under the time versus plasma concentration curve (AUC)	0 ~ 24 hours

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026